Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/986
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Wu, C
Liu, Y
Yang, Y
Zhang, P
Zhong, W
Wang, Y
Wang, Q
Xu, Y
Li, M
Li, X
Zheng, M
Chen, L
Li, H
Acceso Abierto
Atribución-NoComercial-SinDerivadas
SARS-CoV-2 has caused tens of thousands of infections and more than one thousand deaths. There are currently no registered therapies for treating coronavirus infections. Because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden infectious diseases. We systematically analyzed all the proteins encoded by SARS-CoV-2 genes, compared them with proteins from other coronaviruses, predicted their structures, and built 19 structures that could be done by homology modeling. By performing target-based virtual ligand screening, a total of 21 targets (including two human targets) were screened against compound libraries including ZINC drug database and our own database of natural products. Structure and screening results of important targets such as 3-chymotrypsin-like protease (3CLpro), Spike, RNA-dependent RNA polymerase (RdRp), and papain like protease (PLpro) were discussed in detail. In addition, a database of 78 commonly used anti-viral drugs including those currently on the market and undergoing clinical trials for SARS-CoV-2 was constructed. Possible targets of these compounds and potential drugs acting on a certain target were predicted. This study will provide new lead compounds and targets for further in vitro and in vivo studies of SARS-CoV-2, new insights for those drugs currently ongoing clinical studies, and also possible new strategies for drug repositioning to treat SARS-CoV-2 infections.
Acta Pharmaceutica Sinica B
2020
Preimpreso
https://coronavirus.1science.com/item/243004571f16afa02f117c033267556ca3b53e36
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
104261.pdf7.92 MBAdobe PDFView/Open